Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- XAIR
- Price
- 0.24
- Stock movement up
- +0.01 (2.70%)
- Company name
- Beyond Air Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 17.05M
- Ent value
- 12.32M
- Price/Sales
- 7.28
- Price/Book
- 0.58
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 18.68%
- 1 year return
- -85.24%
- 3 year return
- -67.23%
- 5 year return
- -51.10%
- 10 year return
- -
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
XAIR does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.28 |
| Price to Book | 0.58 |
| EV to Sales | 5.26 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 72.19M |
| EPS (TTM) | -1.18 |
| FCF per share (TTM) | -1.17 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.34M |
| Gross profit (TTM) | -2.61M |
| Operating income (TTM) | -56.01M |
| Net income (TTM) | -55.49M |
| EPS (TTM) | -1.18 |
| EPS (1y forward) | -1.75 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -111.59% |
| Operating margin (TTM) | -2391.55% |
| Profit margin (TTM) | -2369.17% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 28.45M |
| Net receivables | 1.00M |
| Total current assets | 38.04M |
| Goodwill | 0.00 |
| Intangible assets | 1.32M |
| Property, plant and equipment | 17.89M |
| Total assets | 53.01M |
| Accounts payable | 1.49M |
| Short/Current long term debt | 13.27M |
| Total current liabilities | 6.60M |
| Total liabilities | 23.72M |
| Shareholder's equity | 29.29M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -48.07M |
| Capital expenditures (TTM) | 7.12M |
| Free cash flow (TTM) | -55.19M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -189.41% |
| Return on Assets | -104.67% |
| Return on Invested Capital | -135.75% |
| Cash Return on Invested Capital | -135.02% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.23 |
| Daily high | 0.24 |
| Daily low | 0.23 |
| Daily Volume | 407K |
| All-time high | 45.00 |
| 1y analyst estimate | 2.50 |
| Beta | -0.18 |
| EPS (TTM) | -1.18 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| XAIR | S&P500 | |
| Current price drop from All-time high | -99.48% | -12.89% |
| Highest price drop | -99.52% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -88.95% | -11.07% |
| Avg time to new high | 1879 days | 12 days |
| Max time to new high | 1878 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
17.05M
Marketcap category
Small-cap
Description
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Employees
107
Website
Investor relations
-
SEC filings
CEO
Steven A. Lisi
Country
USA
City
Garden City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page